Clin Mol Hepatol.
2015 Dec;21(4):344-348. 10.3350/cmh.2015.21.4.344.
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Korea. jheo@pusan.ac.kr
- KMID: 2359814
- DOI: http://doi.org/10.3350/cmh.2015.21.4.344
Abstract
- Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Complications Related to Transarterial Treatment of Hepatocellular Carcinoma: A Comprehensive Review
- Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
- A case of hepatocellular carcinoma in the caudate lobe successfully treated by transcatheter arterial chemoembolization using drug-eluting beads
- A Case of Cryptogenic Organizing Pneumonia after Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
- Conventional versus Drug-eluting Beads Trans-arterial Chemoembolization for Treatment of Hepatocellular Carcinoma at Very Early and Early Stages
